Table of Contents

• 1.   Market Introduction

  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1. Years Considered for the Study
       3.2. Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders

• 2.   Research Methodology

  •   1. Research Data
       1.1. Secondary Data
        1.1.1. Key Data from Secondary Sources
       1.2. Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study

• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Global Organoids And Spheroids Market Variables, Trends and Scope

  •   1. Market LineProducts Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances

• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Organoids And Spheroids Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Global Organoids And Spheroids Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Organoids And Spheroids Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Organoids
       1.1. By Type
        1.1.1. Neural Organoids
        1.1.2. Hepatic Organoids
        1.1.3. Intestinal Organoids
        1.1.4. Other Organoids
       1.2. By Method
        1.2.1. General Submerged Method for Organoid Culture
        1.2.2. Crypt Organoid Culture Techniques
        1.2.3. Air Liquid Interface (ALI) Method for Organoid Culture
        1.2.4. Clonal Organoids from Lgr5+ Cells
        1.2.5. Brain and Retina Organoid Formation Protocol
       1.3. By Source
        1.3.1. Primary Tissues
        1.3.2. Stem Cells
      2. Spheroids
       2.1. By Type
        2.1.1. Multicellular tumor spheroids (MCTS)
        2.1.2. Neurospheres
        2.1.3. Mammospheres
        2.1.4. Hepatospheres
        2.1.5. Embryoid bodies
       2.2. By Method
        2.2.1. Micropatterned Plates
        2.2.2. Low Cell Attachment Plates
        2.2.3. Hanging Drop Method
        2.2.4. Others
       2.3. By Source
        2.3.1. Cell Line
        2.3.2. Primary Cell
        2.3.3. iPSCs Derived Cells

• 8.   Organoids And Spheroids Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Developmental Biology
      2. Personalized Medicine
      3. Regenerative Medicine
      4. Disease Pathology Studies
      5. Drug Toxicity and Efficacy Testing

• 9.   Organoids And Spheroids Market, By End-Use Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Biotechnology and pharmaceutical industries
      2. Academic and Research Institutes
      3. Hospitals and diagnostic centers

• 10.   North America Organoids And Spheroids Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. U.S.A
       2.2. Canada
       2.3. Mexico
      3. Market Size (USD Million) Forecast for North America 2023-2031

• 11.   Latin America Organoids And Spheroids Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Brazil
       2.2. Venezuela
       2.3. Argentina
       2.4. Rest of Latin America
      3. Market Size (USD Million) Forecast for Latin America 2023-2031

• 12.   Europe Organoids And Spheroids Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Germany
       2.2. U.K
       2.3. France
       2.4. Italy
       2.5. Spain
       2.6. Russia
       2.7. Poland
       2.8. Rest of Europe
      3. Market Size (USD Million) Forecast for Europe 2023-2031

• 13.   Asia Pacific Organoids And Spheroids Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Japan
       2.2. China
       2.3. India
       2.4. Australia and New Zealand
       2.5. ASEAN
       2.6. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

• 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. GCC
       2.2. Israel
       2.3. South Africa
       2.4. Rest of MEA
      3. Market Size (USD Million) Forecast for MEA 2023-2031

• 15.   Market Share Analysis and Competitive Landscape
  •   1. Global Landscape - Key Players, Revenue and Presence
      2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Global Emerging Companies
      4. North America - Market Share Analysis and Key Regional Players
      5. Europe - Market Share Analysis and Key Regional Players
      6. Asia Pacific - Market Share Analysis and Key Regional Players
      7. Global Key Player - Growth Matrix
    
• 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

  •   1. 3D Biomatrix
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
      2. 3D Biotek LLC
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
      3. AMS Biotechnology (Europe) Limited
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. ATCC
       4.1. Company Overview
       4.2. Product Portfolio
       4.3. SWOT Analysis
       4.4. Financial Overview
       4.5. Strategic Overview
      5. Cellesce Ltd.
       5.1. Company Overview
       5.2. Product Portfolio
       5.3. SWOT Analysis
       5.4. Financial Overview
       5.5. Strategic Overview
      6. Corning Incorporated
       6.1. Company Overview
       6.2. Product Portfolio
       6.3. SWOT Analysis
       6.4. Financial Overview
       6.5. Strategic Overview
      7. Greiner Bio-One
       7.1. Company Overview
       7.2. Product Portfolio
       7.3. SWOT Analysis
       7.4. Financial Overview
       7.5. Strategic Overview
      8. Hubrecht Organoid Technology (HUB)
       8.1. Company Overview
       8.2. Product Portfolio
       8.3. SWOT Analysis
       8.4. Financial Overview
       8.5. Strategic Overview
      9. InSphero/Perkin Elmer
       9.1. Company Overview
       9.2. Product Portfolio
       9.3. SWOT Analysis
       9.4. Financial Overview
       9.5. Strategic Overview
      10. Kuraray
       10.1. Company Overview
       10.2. Product Portfolio
       10.3. SWOT Analysis
       10.4. Financial Overview
       10.5. Strategic Overview
      11. Lonza
       11.1. Company Overview
       11.2. Product Portfolio
       11.3. SWOT Analysis
       11.4. Financial Overview
       11.5. Strategic Overview
      12. Merck KGaA
       12.1. Company Overview
       12.2. Product Portfolio
       12.3. SWOT Analysis
       12.4. Financial Overview
       12.5. Strategic Overview
      13. Prellis Biologics
       13.1. Company Overview
       13.2. Product Portfolio
       13.3. SWOT Analysis
       13.4. Financial Overview
       13.5. Strategic Overview
      14. STEMCELL Technologies Inc.
       14.1. Company Overview
       14.2. Product Portfolio
       14.3. SWOT Analysis
       14.4. Financial Overview
       14.5. Strategic Overview
      15. Thermo Fisher Scientific, Inc.
       15.1. Company Overview
       15.2. Product Portfolio
       15.3. SWOT Analysis
       15.4. Financial Overview
       15.5. Strategic Overviewx

• 17.   Pre and Post COVID-19 Impact

  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by
                 administrations
      5. The overall economic slowdown of the developing and developed nations

• 18.   FutureWise SME Key Takeaway Points for Client